BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 4970415)

  • 1. [Chemo-antibiotic resis tance and clinicoradiologic patterns of the disease in patients with chronic pulmonary tuberculosis].
    Giura R
    G Ital Mal Torace; 1967; 21(4):205-9. PubMed ID: 4970415
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current bacteriologic and clinical aspects of chemo-antibiotic therapy of pulmonary tuberculosis].
    Saltini C; Velluti G; Mantovani P
    Arch Monaldi; 1978; 33(4):251-79. PubMed ID: 116622
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and bacteriological aspects of the drug resistance of Mycobacterium tuberculosis in patients with chronic destructive pulmonary tuberculosis].
    Korotaev GA; Kozulitsyna TI; Tret'iakova EA; Mamed'iarova FA
    Probl Tuberk; 1986; (7):32-6. PubMed ID: 3094001
    [No Abstract]   [Full Text] [Related]  

  • 4. [Epidemiologic aspects of resistance to ATA (Antitubercular Agents)].
    Zrilić V; Muzikravić T
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():29-37. PubMed ID: 4216919
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes and patterns of drug resistance of mycobacterium tuberculosis in patients with pulmonary tuberculosis (by data of the microbiological laboratory of research production association "Phthysiology")].
    Gorokhova TV
    Probl Tuberk; 1997; (2):33-5. PubMed ID: 9235582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [2 cases of drug-resistant pulmonary tuberculosis treated with ofloxacin].
    Krasucka-Kluźniak A; Krakówka P
    Pneumonol Pol; 1989 Apr; 57(4):249-52. PubMed ID: 2516906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical course and chemotherapy of hyperchronic destructive pulmonary tuberculosis].
    Mamolat AS; Bialik IB; Khutorskaia VD
    Probl Tuberk; 1985; (10):24-8. PubMed ID: 3934660
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness of ethambutol in chronic pulmonary tuberculosis].
    Golli V; Stefanin E; Chiper P; Stefănescu I; Popescu-Crivina IM; Anghel E; Kosinski E; Daha A; Kosinski M; Floricel N
    Ftiziologia; 1972; 21(5):489-94. PubMed ID: 4632131
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of drug resistance and blood bacteriostatic activity in patients with pulmonary tuberculosis].
    Kochetov BI; Gur'ian IE
    Probl Tuberk; 1971; 49(6):64-7. PubMed ID: 5000745
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience in treating tuberculosis patients in the IB outpatient registry group].
    Smirnov GA; Valitova ZIu; Fattakhova RM; Anastas'ev VS
    Probl Tuberk; 1986; (4):12-5. PubMed ID: 3086863
    [No Abstract]   [Full Text] [Related]  

  • 11. [Secondary drug sensitivity of tubercle bacilli in chronic sputum-positive tuberculosis patients].
    Telejko Z
    Gruzlica; 1970 Oct; 38(11):1101-4. PubMed ID: 4992233
    [No Abstract]   [Full Text] [Related]  

  • 12. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
    Fomicheva NI; Terentieva AS
    Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical aspects of secondary resistance in pulmonary tuberculosis].
    Gugić B
    Plucne Bolesti; 1985; 37(1-2):22-7. PubMed ID: 3934690
    [No Abstract]   [Full Text] [Related]  

  • 14. [Primary resistance of Mycobacterium tuberculosis. Bacteriological and epidemiological aspects].
    Nitti V
    Arch Monaldi; 1972; 27(4):454-74. PubMed ID: 4217601
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ethambutol in the treatment of chronic pulmonary tuberculosis with bacilli resistant to tuberculostatics].
    Anastasatu C; Kaufman S; Barcan F; Gheorghiu M; Cristea M; Ulpian C; Iancovici O
    Ftiziologia; 1971; 20(4):373-9. PubMed ID: 5005706
    [No Abstract]   [Full Text] [Related]  

  • 16. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
    Khomenko AG; Chukanov VI; Korneev AA
    Probl Tuberk; 1996; (6):42-4. PubMed ID: 9019768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of aggravating factors on the effectiveness of the treatment of newly detected patients with destructive pulmonary tuberculosis].
    Zozuliak VI
    Vrach Delo; 1988 Jun; (6):54-5. PubMed ID: 3138824
    [No Abstract]   [Full Text] [Related]  

  • 18. [Epidemiological and clinical significance of resistant tuberculosis bacteria].
    Sighart H
    Wien Med Wochenschr; 1968 Oct; 118(43):923-5. PubMed ID: 4973923
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preliminary results of rifabutine (ansamycine LM 427) treatment of patients with newly detected and chronic pulmonary tuberculosis and Mycobacterium infections].
    Rowińska-Zakrzewska E; Słupek A; Graczyk J; Zwolska-Kwiek Z; Augustynowicz-Kopeć E; Stambrowska A; Byszewska D; Latoś E; Pilarska A; Andrzejczyk Z
    Pneumonol Alergol Pol; 1992; 60(9-10):81-8. PubMed ID: 1338003
    [No Abstract]   [Full Text] [Related]  

  • 20. [Incidence of drug resistance of Mycobacterium tuberculosis].
    Terentieva AS
    Vrach Delo; 1979 Mar; (3):28-30. PubMed ID: 109992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.